Radikale Lebensverl�ngerung

Forum f�r Lebensverl�ngerung � Radikale Lebensverl�ngerung, Sport, Verschiedenes � Radikale Lebensverl�ngerung � Geroprotektoren

Themen-Einstellungen

Thema drucken

Bereich wechseln

News, Aktuelles, Umfragen Aktuelles, News Ern�hrung und Nahrungserg�nzung Heilung, Pr�vention und Verj�ngung durch Ern�hrung Di�ten, Gewichtsreduktion, Heilfasten Nahrungserg�nzung Gesundheitsprobleme Erkrankungen, Diagnosen, Therapien Krebserkrankungen Kardiovaskul�re Erkankungen Demenzerkrankungen Diabetes mellitus und metabolisches Syndrom Sars-CoV-2 Pandemie Labor (interner Bereich) Hormonwerte (interner Bereich) Hormonwerte, Labor (�ffentlicher Bereich) Labor (�ffentlicher Bereich) Hormonwerte (�ffentlicher Bereich) Radikale Lebensverl�ngerung, Sport, Verschiedenes Radikale Lebensverl�ngerung Bewegung und Sport Verschiedenes

#1 | Geroprotektoren datum

09.06.2016 22:46 (zuletzt bearbeitet: 09.06.2016 22:57)

Geroprotektoren sind Substanzen, die den Alterungsprozess verlangsamen.

Im Jahre 2009 gab es 24 bekannte Geroprotektoren. Mittlerweile kennen wir weit über 200 Substanzen, die das Altern hinauszögern können. Doch nach welchen Kriterien kann man eine "Best of"-Liste erstellen?

Alexey Moskalev und Brian K. Kennedy schlagen dafür folgende Kriterien vor:

Hauptkriterien

Verlängerung der Lebensspanne
Günstige Beeinflussung von Alters-Biomarkern
Geringe Toxizität
Geringe Nebenwirkungen bei therapeutischer Dosierung
Verbesserung der Lebensqualität

Nebenkriterien

Evolutionär konservierter Wirkmechanismus
Wirksamkeit über viele Spezies hinweg
Einfluss auf mehrere altersassoziierte todesverursachende Erkankungen
Erhöhung der Stressresistenz

Sortiert man mit diesem Algorithmus unter den bekannten Geroprotektoren, ragen folgende Substanzen heraus, die in den Augen der Autoren großes Potential auch beim Menschen haben könnten:

Zitat:

Acarbose
Acarbose is an α-glucosidase inhibitor used to treat diabetes mellitus. Treated with this compound, male UM-HET3 mice had 22% longer lifespan (Harrison et al., 2014). It has acceptable acute toxicity � mouse LD50 oral is 24 gm kg−1 (Tomasulo, 2002). Acarbose is considered to be well-tolerable drug with adverse effects not significantly differing from placebo (Hotta et al., 1993). Acarbose reduces blood glucose concentrations, blood pressure, triglycerides, the progression of intima media thickness, and incidence of cardiovascular events and of newly diagnosed hypertension, and it demonstrates beneficial effects on overweight individuals and downregulates biomarkers of low-grade inflammation (Hanefeld & Schaper, 2008).

Deprenyl
Deprenyl is a selective MAO-B inhibitor used to treat major depression and early-stage Parkinson disease. It prolongs lifespan in male rat (Kitani et al., 1993). No significant acute toxicological data for this compound were identified in literature search (mouse LD50 intraperitoneal 200 mg kg−1) (Kane et al., 1988). Deprenyl is also well tolerated (Robottom, 2011). Deprenyl protects human neurons from apoptosis induced by various kinds of insults by interfering with early apoptotic signaling events and may be applicable to delay the deterioration of neurons during advancing aging (Maruyama & Naoi, 1999; Magyar et al., 2004).

D-glucosamine
D-glucosamine is an amino sugar and a potent drug for the treatment of arthritis, although its effectiveness is controversial (Burdett & McNeil, 2012). Nevertheless, it is able to promote lifespan of nematodes and C57BL/6NRj mice (Weimer et al., 2014). This compound has very low acute toxicity and is safe for everyday use (Reginster et al., 2001). Current use of glucosamine was associated with a significant decreased risk of death from cancer (HR 0.87 95% CI 0.76-0.98) and with a large risk reduction for death from respiratory diseases (HR 0.59 95% CI 0.41-0.83) (Pocobelli et al., 2010; Bell et al., 2012). Glucosamine supplementation can significantly decrease risk of lung cancer in humans (Brasky et al., 2011). A meta-analysis has shown that glucosamine has lowest risk of adverse effects compared with other treatments (Diarecin and NSAIDs) (Kongtharvonskul et al., 2015). The oral supplementation of glucosamine can potentially improve cutaneous aging in human and reduce the appearance of visible wrinkles and fine lines of the skin (Murad & Tabibian, 2001).

Dihydroergocristine methanesulfonate
Dihydroergocristine methanesulfonate is an fungally derived alkaloid salt and a potent vasodilator (Valli et al., 1984). It is one of the 60 compounds identified in a screen for increased longevity in C. elegans (Ye et al., 2014). In two studies (Aranda et al., 1992; Milvio, 1992), dihydroergocristine was shown as safe and well tolerated with rare side effects including mild gastralgia, nausea, and dyspepsia in aged patients with senile dementia of Alzheimer type. Dihydroergocristine methanesulfonate in some studies has statistically significant positive effects on symptoms of age-related cognitive dysfunction (Wadworth & Chrisp, 1992).

Ellagic acid
Ellagic acid is a natural polyphenol found in numerous edible plants. Its ability to prolong C. elegans lifespan is proposed to be due to a hormetic effect (Saul et al., 2011). This substance has also low acute toxicity � rat LD50 oral > 20 gm kg−1 (Tomasulo, 2002). Study on rats showed a potentially good tolerability (Tasaki et al., 2008). Ellagic acid prevents collagen destruction and inflammatory responses caused by UV-B-induced photoaging in HaCaT keratinocytes and human dermal fibroblasts (Bae et al., 2010).

Glutathione
Glutathione is a tripeptide with notable antioxidant effect. Glutathione prevents aging-associated oxidation of proteins in the crystalline lens (Kamei, 1993).It is also able to promote C. elegans lifespan (Shibamura et al., 2009) and has rather low acute toxicity � mouse LD50 oral 5 gm kg−1 (Tomasulo, 2002). A recent study showed that glutathione was well tolerated with few side effects (Richie et al., 2015).

Metformin
Metformin is an oral antidiabetic drug of the biguanide class that is widely prescribed as an early-stage drug for type II diabetes. It enhances longevity is a range of model organisms: C. elegans (Cabreiro et al., 2013), D. melanogaster (Slack et al., 2012), and M. musculus (Martin-Montalvo et al., 2013). However, it should be noted that there are studies showing no effect or only a very small effect of metformin in rats and rodents with normal genetics and longevity (https://www.ncbi.nlm.nih.gov/pubmed/20304770, http://www.ncbi.nlm.nih.gov/pubmed/23900241). It has acceptable acute toxicity � mouse LD50 oral 1450 mg kg−1 (Tomasulo, 2002) � and is well tolerated (Giugliano et al., 1993). Serious but rare adverse effects include lactic acidosis (mostly linked to alcoholism due to depletion of NAD+ stores), heart failure, respiratory disease (due to inadequate oxygenation of tissues), and impaired renal function. Metformin treatment confers insulin sensitivity, leads to weight loss, and improves lipid profiles (Salpeter et al., 2008).

Rapamycin
Rapamycin is an antifungal agent with immunosuppressive and antiproliferative effects. It has a lifespan-prolonging effect in several studies on different model organisms, including S. cerevisiae (Powers et al., 2006; Medvedik et al., 2007), C. elegans (Robida-Stubbs et al., 2012), D. melanogaster (Moskalev & Shaposhnikov, 2010), and M. musculus (Harrison et al., 2009; Fok et al., 2014; Miller et al., 2014). It has acceptable acute toxicity � mouse LD50 oral > 2500 mg kg−1 (Vezina et al., 1975) � although it can induce a range of reversible but concerning side effects (Soefje et al., 2011). Other rapamycin derivatives (termed rapalogs) appear to have similar effects. A majority of reports also indicate that rapamycin delays pathologies of aging in mice and protects against age-related diseases, including cardiac and neurodegenerative syndromes, as well as neoplasms (Johnson et al., 2013; Lamming et al., 2013). Rapamycin also is reported to suppress nuclear defects in cells isolated from Hutchinson�Gilford progeria syndrome, although reports of the drug have not been reported in mouse models of the disease (Oyanagui, 1984; Pocobelli et al., 2010).67,68

Spermidine
Spermidine is a natural polyamine compound found in animal tissues. It is reported to promote lifespan of yeast, flies, worms, human cells, and mice (Eisenberg et al., 2009). Spermidine has acceptable acute toxicity � mouse LD30 oral 1 gm kg−1 (Oyanagui, 1984). Administration of spermidine, whose intracellular concentration declines during human aging, markedly extends the lifespan of human immune cells. In aging human cells, spermidine treatment triggers epigenetic deacetylation of histone H3 through inhibition of histone acetyltransferases, enhances autophagic flux, and suppresses oxidative stress and necrosis (Eisenberg et al., 2009).

Tyrosol
Tyrosol is natural phenolic antioxidant, a derivative of phenethil alcohol. It is able to increase both mean and maximum lifespan in C. elegans (Canuelo et al., 2012) and is well tolerated (Tuck & Hayball, 2002). Tyrosol can afford considerable protection against aging-associated heart deterioration (Owen et al., 2000). Several studies showed a cardioprotective role of tyrosol (Samuel et al., 2008; Smol'iakova et al., 2010; Sun et al., 2015). Tyrosol's cardiovascular benefits are likely due to its ability to prevent oxidation of LDL (Covas et al., 2006; Castaner et al., 2012). Also, tyrosol ameliorated hyperglycemia by regulating key enzymes of carbohydrate metabolism in streptozotocin-induced diabetic rats (Chandramohan et al., 2015). A human study of tyrosol-rich products (white wine and virgin olive oil) demonstrated an anti-inflammatory effect (Migliori et al., 2015). Tyrosol has a potent anti-allergic effect by inhibiting the degranulation of mast cells and expression of inflammatory cytokines (Je et al., 2015). Tyrosol has very low acute toxicity (LD50 was found to be 2700 and 1700 mg kg−1 in mice after intragastric and intraperitoneal injection, respectively, and 7079 mg kg−1 in rats after intragastric administration). No toxicity was observed after 3 months of chronic intragastric administration of p-tyrosol at the doses of 200 mg kg−1 in male rats and 10 mg kg−1 in dogs (Saratikov & Krasnov, 2004).

Vinpocetine
Vinpocetine is a semisynthetic derivative of the alkaloid vincamine with nootropic effects. It is another of the 60 compounds identified in a recent screen for enhanced longevity in C. elegans (Ye et al., 2014). It has acceptable acute toxicity � mouse LD50 oral 534 mg kg−1 (Cholnoky & Domok, 1976). In an 18-month study, vinpocetine was reported safe and had a good tolerability during the whole study period (Valikovics et al., 2012). In another study, vinpocetine failed to show effectiveness in treatment Alzheimer disease, but there also were no significant side effects from drug therapy (Thal et al., 1989). Vinpocetine significantly inhibits in vitro aging of human erythrocytes (Bayer et al., 1988).

Quelle:

Developing criteria for evaluation of geroprotectors as a key stage toward translation to the clinic
http://onlinelibrary.wiley.com/doi/10.1111/acel.12463/full

Eine Datenbank mit bekannten Geroprotektoren findet sich hier:
http://geroprotectors.org/

La_Croix, Stef, CRONos und version2 haben sich bedankt!

Radikale Lebensverl�ngerung » Geroprotektoren